Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibronectin-binding proteins (FnBPs) are a class of microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) primarily found in Gram-positive bacteria like Staphylococcus aureus (Source: UniProt P0C0L5). These proteins mediate the critical first step of infection by binding to host fibronectin, facilitating bacterial attachment to the extracellular matrix and subsequent colonization (Source: PMID: 12730535). Beyond simple adhesion, FnBPs can induce the internalization of bacteria into host cells, such as endothelial cells and osteoblasts, which allows the pathogen to evade the immune system and persist in tissues (Source: PMID: 24103447). This mechanism is central to the development of chronic infections, including endocarditis, osteomyelitis, and prosthetic joint infections (Source: StatPearls). As therapeutic targets, FnBPs are being explored for anti-adhesion strategies, where inhibitors like the pUR4 peptide or specific antibodies aim to block the binding interface and prevent the initiation of disease (Source: PMID: 24103447). These approaches are particularly relevant in the context of rising antibiotic resistance, as they target virulence factors rather than essential growth pathways.
Competitive inhibition of the bacterial binding domain to host fibronectin, preventing adhesion and internalization [PMID: 24103447].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibronectin-binding protein (FnBP).